Nanomaterials for clinical applications : (Record no. 82406)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 04093cam a2200505 a 4500 |
001 - CONTROL NUMBER | |
control field | on1141223334 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20230516165841.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr |n||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200223s2020 ne o 001 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | YDX |
Language of cataloging | eng |
Description conventions | pn |
Transcribing agency | YDX |
Modifying agency | OPELS |
-- | UKMGB |
-- | UKAHL |
-- | OCLCF |
-- | EBLCP |
-- | OCLCQ |
-- | OCLCO |
-- | K6U |
-- | OCLCQ |
015 ## - NATIONAL BIBLIOGRAPHY NUMBER | |
National bibliography number | GBC027244 |
Source | bnb |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
Record control number | 019718644 |
Source | Uk |
019 ## - | |
-- | 1141511300 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780128168769 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0128168765 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9780128167052 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 012816705X |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)1141223334 |
Canceled/invalid control number | (OCoLC)1141511300 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RS201.N35 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 620/.5 |
Edition number | 23 |
245 00 - TITLE STATEMENT | |
Title | Nanomaterials for clinical applications : |
Remainder of title | case studies in nanomedicines / |
Statement of responsibility, etc. | edited by Natassa Pippa and Costas Demetzos. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Amsterdam : |
Name of publisher, distributor, etc. | Elsevier, |
Date of publication, distribution, etc. | 2020. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
490 1# - SERIES STATEMENT | |
Series statement | Micro and nano technologies |
500 ## - GENERAL NOTE | |
General note | Includes index. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Front Cover -- Nanomaterials for Clinical Applications -- Copyright Page -- Contents -- List of contributors -- 1. Solid lipid nanoparticles in dermaceuticals -- 1.1 General introduction -- 1.2 Why solid lipid nanoparticles? -- 1.2.1 Formulation aspects -- 1.2.2 Physiological aspects -- 1.3 Evolution of lipidic nanoparticles from solid lipid nanoparticles to nanostructured lipid carriers -- 1.4 Cosmetic and topical applications of solid lipid nanoparticles -- 1.5 Skin penetration with solid lipid nanoparticles -- 1.6 Mechanism of drug penetration with solid lipid nanoparticles |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 1.7 Incorporation into semisolid vehicle -- 1.8 Case studies of successful topical delivery with lipidic nanoparticles -- 1.8.1 Delivery of antimicrobials -- 1.9 Delivery of agents for other skin diseases -- 1.9.1 Solid lipid nanoparticles for cosmetic applications -- 1.10 Conclusions -- References -- 2. Cyclodextrin-based drug delivery systems -- 2.1 Cyclodextrins-structure, physiochemical properties, and toxicological profile -- 2.2 Cyclodextrin inclusion complexes-formation, stability, and application in drug delivery -- 2.3 Cyclodextrin-based products in clinical practice |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 2.3.3.1 Cyclodextrins in control of obesity and hyperlipidemia -- References -- 3. Lipid vesicles for (trans)dermal administration -- 3.1 (Trans)dermal drug-delivery systems -- 3.1.1 Human skin barrier to xenobiotics -- 3.2 Lipid vesicles for breaching the skin barrier -- 3.2.1 Conventional liposomes -- 3.2.2 Transfersomes -- 3.2.3 Ethanol-based lipid vesicles -- 3.2.3.1 Ethosomes -- 3.2.3.2 Transethosomes -- 3.2.3.3 Other lipid vesicles -- 3.3 Liposomal formulation in clinics -- 3.3.1 Conventional liposomes -- 3.3.2 Transfersomes -- 3.3.3 Ethosomes -- 3.4 Final remarks -- References |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 4. Stimuli-responsive nanocarriers for drug delivery -- 4.1 Introduction -- 4.2 Types of stimuli -- 4.2.1 pH-responsive nanosystems -- 4.2.2 Thermoresponsive nanosystems -- 4.3 Development of chimeric stimuli-responsive liposomes with incorporated stimuli-responsive polymers -- 4.3.1 pH-responsive liposomes -- 4.3.2 Thermoresponsive liposomes -- 4.4 Thermotropic behavior of stimuli-responsive liposomes -- 4.4.1 Thermal analysis on pH-responsive liposomes -- 4.4.2 Thermal analysis of thermoresponsive liposomes -- 4.5 Physicochemical properties of stimuli-responsive liposomes |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanoparticles. |
9 (RLIN) | 7280 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanoparticles |
Authority record control number or standard number | (DNLM)D053758 |
9 (RLIN) | 7280 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanoparticules. |
Authority record control number or standard number | (CaQQLa)201-0262530 |
9 (RLIN) | 68594 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanoparticles. |
Source of heading or term | fast |
Authority record control number or standard number | (OCoLC)fst01032624 |
9 (RLIN) | 7280 |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pippa, Natassa. |
9 (RLIN) | 68595 |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Demetzos, Costas. |
9 (RLIN) | 68596 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Title | Nanomaterials for clinical applications. |
Place, publisher, and date of publication | Amsterdam : Elsevier, 2020 |
International Standard Book Number | 012816705X |
-- | 9780128167052 |
Record control number | (OCoLC)1109769616 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Micro & nano technologies. |
9 (RLIN) | 68597 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | ScienceDirect |
Uniform Resource Identifier | <a href="https://www.sciencedirect.com/science/book/9780128167052">https://www.sciencedirect.com/science/book/9780128167052</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | eBooks |
No items available.